Globus Medical (GMED) Tops Q4 EPS by 9c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Globus Medical Reports Full Year and Fourth Quarter 2015 Results
February 24, 2016 4:50 PM ESTAUDUBON, Pa., Feb. 24, 2016 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal implant manufacturer, today announced its financial results for the fourth quarter and year ended December 31, 2015.
Fourth Quarter:
Worldwide sales increased 10.7% as reported to $142.6 million, or 11.5% on a constant currency basisFourth quarter net income was $37.6 millionEarnings per fully diluted share were $0.39Non-GAAP Adjusted EBITDA was 37.7% of salesFull Year 2015:
Worldwide sales increased 14.8% as reported to $544.8 million, or 16.0% on a constant currency basisNet income... More